Bright et al. (2023). A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors.
A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors.
Bright, E. E., Finkelstein, L. B., Nealis, M. S., Genung, S. R., Wrigley, J., Gu, H. C. J., Schmiege, S. J., & Arch, J. J. (2023). A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors. J Clin Oncol, 41(28), 4548-4561. https://doi.org/10.1200/JCO.23.00697
McGrady et al. (2023). Barriers to medication adherence among adolescents and young adults with cancer.
Barriers to medication adherence among adolescents and young adults with cancer.
McGrady, M. E., Ketterl, T. G., Norris, R. E., Perentesis, J. P., Pettee, D., Mara, C. A., Breen, G., & Pai, A. L. H. (2023). Barriers to medication adherence among adolescents and young adults with cancer. Pediatric Blood & Cancer, 70(3), 1-9. https://doi.org/10.1002/pbc.30186
Yussof et al. (2022). Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review.
Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review.
Yussof, I., Mohd Tahir, N. A., Hatah, E., & Mohamed Shah, N. (2022). Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review. Breast, 62, 22-35. https://doi.org/10.1016/j.breast.2022.01.012
Yu et al. (2021). A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study.
A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study.
Yu, J., Wu, J., Huang, O., Chen, X., & Shen, K. (2021). A Smartphone-Based App to Improve Adjuvant Treatment Adherence to Multidisciplinary Decisions in Patients With Early-Stage Breast Cancer: Observational Study. J Med Internet Res, 23(9), e27576. https://doi.org/10.2196/27576
Rogala et al. (2019). Oral Anticancer Therapy: Management of Drug Interactions.
Oral Anticancer Therapy: Management of Drug Interactions.
Rogala, B. G., Charpentier, M. M., Nguyen, M. K., Landolf, K. M., Hamad, L., & Gaertner, K. M. (2019). Oral Anticancer Therapy: Management of Drug Interactions. J Oncol Pract, 15(2), 81-90. https://doi.org/10.1200/JOP.18.00483
Paranjpe et al. (2019). Identifying adherence barriers to oral endocrine therapy among breast cancer survivors.
Identifying adherence barriers to oral endocrine therapy among breast cancer survivors.
Paranjpe, R., John, G., Trivedi, M., & Abughosh, S. (2019). Identifying adherence barriers to oral endocrine therapy among breast cancer survivors. Breast Cancer Res Treat, 174(2), 297-305. https://doi.org/10.1007/s10549-018-05073-z
Moon et al. (2017). Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
Moon, Z., Moss-Morris, R., Hunter, M. S., & Hughes, L. D. (2017). Understanding tamoxifen adherence in women with breast cancer: A qualitative study. Br J Health Psychol, 22(4), 978-997. https://doi.org/10.1111/bjhp.12266
Moon et al. (2017). Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.
Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.
Moon, Z., Moss-Morris, R., Hunter, M. S., Carlisle, S., & Hughes, L. D. (2017). Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Prefer Adherence, 11, 305-322. https://doi.org/10.2147/PPA.S126651